FDA Approved: COMPLERA — Original Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved COMPLERA as an Original Application (NDA 202123) for HIV-1 infection. It is a single-tablet regimen containing emtricitabine, rilpivirine hydrochlo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• COMPLERA (Emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate)

Snippet

ORIG AP for COMPLERA (EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE)